Nigel J. Liverton

3.6k total citations
61 papers, 1.8k citations indexed

About

Nigel J. Liverton is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Nigel J. Liverton has authored 61 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 13 papers in Organic Chemistry and 9 papers in Infectious Diseases. Recurrent topics in Nigel J. Liverton's work include Ion channel regulation and function (11 papers), Neuroscience and Neuropharmacology Research (9 papers) and Hepatitis C virus research (9 papers). Nigel J. Liverton is often cited by papers focused on Ion channel regulation and function (11 papers), Neuroscience and Neuropharmacology Research (9 papers) and Hepatitis C virus research (9 papers). Nigel J. Liverton collaborates with scholars based in United States, Germany and Italy. Nigel J. Liverton's co-authors include Amos B. Smith, Kevin T. Nguyen, Christopher F. Claiborne, Regina Zibuck, Charles McIntyre, David A. Claremon, Peter T. Meinke, John A. McCauley, Joseph J. Lynch and Rose M. Cubbon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Nigel J. Liverton

60 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nigel J. Liverton United States 24 726 711 212 201 188 61 1.8k
John W. Ellingboe United States 25 893 1.2× 906 1.3× 81 0.4× 122 0.6× 115 0.6× 54 1.8k
Allan S. Wagman United States 17 1.4k 1.9× 447 0.6× 106 0.5× 285 1.4× 61 0.3× 28 2.2k
Mario A. Pagano Italy 29 1.9k 2.6× 316 0.4× 148 0.7× 368 1.8× 48 0.3× 70 2.8k
Jon P. Miller United States 25 1.3k 1.8× 381 0.5× 187 0.9× 130 0.6× 40 0.2× 51 1.8k
John J. Piwinski United States 21 538 0.7× 565 0.8× 113 0.5× 90 0.4× 65 0.3× 49 1.1k
Juan C. Jaén United States 32 1.2k 1.7× 1.1k 1.5× 256 1.2× 809 4.0× 72 0.4× 102 3.4k
J. Romine United States 19 362 0.5× 441 0.6× 124 0.6× 33 0.2× 265 1.4× 31 1.0k
Brian Dymock Singapore 30 1.8k 2.5× 553 0.8× 50 0.2× 513 2.6× 104 0.6× 78 2.9k
Donald S. Karanewsky United States 30 1.8k 2.5× 1.1k 1.5× 218 1.0× 362 1.8× 17 0.1× 77 3.0k
Neng‐Yang Shih United States 20 564 0.8× 583 0.8× 96 0.5× 86 0.4× 92 0.5× 57 1.3k

Countries citing papers authored by Nigel J. Liverton

Since Specialization
Citations

This map shows the geographic impact of Nigel J. Liverton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel J. Liverton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel J. Liverton more than expected).

Fields of papers citing papers by Nigel J. Liverton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel J. Liverton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel J. Liverton. The network helps show where Nigel J. Liverton may publish in the future.

Co-authorship network of co-authors of Nigel J. Liverton

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel J. Liverton. A scholar is included among the top collaborators of Nigel J. Liverton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel J. Liverton. Nigel J. Liverton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Michael W., Cindy Meyer, Aitor Garzia, et al.. (2025). Discovery, Optimization, and Evaluation of Non-Nucleoside SARS-CoV-2 NSP14 Inhibitors. Journal of Medicinal Chemistry. 68(18). 19076–19106.
2.
3.
Michino, Mayako, Michael W. Miller, Yoshiyuki Fukase, et al.. (2024). Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable In Vivo Studies: Discovery of TDI-11055. ACS Medicinal Chemistry Letters. 15(4). 524–532. 2 indexed citations
4.
Ginn, John D., Tomasz Kochańczyk, Xiuju Jiang, et al.. (2024). Indazole to 2‐Cyanoindole Scaffold Progression for Mycobacterial Lipoamide Dehydrogenase Inhibitors Achieves Extended Target Residence Time and Improved Antibacterial Activity. Angewandte Chemie International Edition. 63(44). e202407276–e202407276. 3 indexed citations
5.
Ginn, John D., Xiuju Jiang, Mayako Michino, et al.. (2021). Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding Interactions. ACS Infectious Diseases. 7(2). 435–444. 5 indexed citations
6.
Brodbeck, Jens, Zhaoping Liu, Anke Meyer‐Franke, et al.. (2011). Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors. Journal of Biological Chemistry. 286(19). 17217–17226. 84 indexed citations
7.
Carroll, Steve S., John A. McCauley, Paul J. Coleman, et al.. (2010). MK-5172, a Novel Macrocyclic Inhibitor of NS3/4a Protease Demonstrates Efficacy Against Viral Resistance in the Chimpanzee Model of Chronic Hepatitis C Virus Infection. Antiviral Research. 86(1). A21–A21. 1 indexed citations
8.
Beshore, Douglas C., Nigel J. Liverton, Charles McIntyre, et al.. (2010). Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel. Bioorganic & Medicinal Chemistry Letters. 20(8). 2493–2496. 12 indexed citations
9.
Francesco, Maria Emilia Di, et al.. (2009). Phosphorous acid analogs of novel P2–P4 macrocycles as inhibitors of HCV–NS3 protease. Bioorganic & Medicinal Chemistry Letters. 19(9). 2574–2578. 12 indexed citations
10.
McCauley, John A., Michael T. Rudd, Kevin T. Nguyen, et al.. (2008). Bismacrocyclic Inhibitors of Hepatitis C NS3/4a Protease. Angewandte Chemie International Edition. 47(47). 9104–9107. 18 indexed citations
11.
Graham, Donald J., L K Handt, Christine Fandozzi, et al.. (2008). Evaluation of MK-7009, A Novel Macrocyclic Inhibitor of NS3/4A Protease, in the Chimpanzee Model of Chronic Hepatitis C Virus Infection. Antiviral Research. 78(2). A23–A23. 2 indexed citations
12.
Nguyen, Kevin T., Christopher F. Claiborne, John A. McCauley, et al.. (2007). Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(14). 3997–4000. 19 indexed citations
13.
Marino, Michael J., Jeannine Hess, & Nigel J. Liverton. (2005). Targeting the Metabotropic Glutamate Receptor mGluR4 for the Treatment of Diseases of the Central Nervous System. Current Topics in Medicinal Chemistry. 5(9). 885–895. 26 indexed citations
14.
Bednář, Bohumil, Michael E. Cunningham, Laszlo Kiss, et al.. (2004). Kinetic characterization of novel NR2B antagonists using fluorescence detection of calcium flux. Journal of Neuroscience Methods. 137(2). 247–255. 6 indexed citations
15.
Lynch, Joseph J., Joseph J. Salata, Audrey A. Wallace, et al.. (2002). Antiarrhythmic Efficacy of Combined IKs and β-Adrenergic Receptor Blockade. Journal of Pharmacology and Experimental Therapeutics. 302(1). 283–289. 7 indexed citations
16.
McIntyre, Charles, G. S. PONTICELLO, Nigel J. Liverton, et al.. (2002). Pyridazine based inhibitors of p38 MAPK. Bioorganic & Medicinal Chemistry Letters. 12(4). 689–692. 15 indexed citations
17.
Thompson, James E., Rose M. Cubbon, Richard Cummings, et al.. (2002). Photochemical preparation of a pyridone containing tetracycle: A jak protein kinase inhibitor. Bioorganic & Medicinal Chemistry Letters. 12(8). 1219–1223. 224 indexed citations
18.
McCauley, John A., Cory R. Theberge, & Nigel J. Liverton. (2000). Chemoselective Reactions of Amidines:  Selective Formation of Iminopyrimidine Regioisomers. Organic Letters. 2(21). 3389–3391. 12 indexed citations
19.
Lisnock, JeanMarie, Betsy Frantz, Edward A. O’Neill, et al.. (1998). Molecular Basis for p38 Protein Kinase Inhibitor Specificity. Biochemistry. 37(47). 16573–16581. 81 indexed citations
20.
Baker, Raymond, Paul D. Leeson, Nigel J. Liverton, & Janusz J. Kulagowski. (1990). Identification of (1S)-phosphoryloxy-(2R,4S)-dihydroxycyclohexane as a potent inhibitor of inositol monophosphatase. Journal of the Chemical Society Chemical Communications. 462–462. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John W. Ellingboe Breakdown of academic impact, for papers by Allan S. Wagman Breakdown of academic impact, for papers by Mario A. Pagano Breakdown of academic impact, for papers by Jon P. Miller Breakdown of academic impact, for papers by John J. Piwinski Breakdown of academic impact, for papers by Juan C. Jaén Breakdown of academic impact, for papers by J. Romine Breakdown of academic impact, for papers by Brian Dymock Breakdown of academic impact, for papers by Donald S. Karanewsky Breakdown of academic impact, for papers by Neng‐Yang Shih
Rankless by CCL
2026